Breast Cancer Campaign is seeking expressions of interests for research aiming to tackle the gaps in risk and prevention of breast cancer as identified in the breast cancer research gap analysis entitled “Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer”.

They will consider an expression of interest to tackle any of the gaps in risk and prevention of breast cancer. However, in light of the NICE clinical guidance being updated to recommend the use of Tamoxifen and Raloxifene in the prevention setting, they particularly welcome expressions of interest relating to this area of chemoprevention.

The deadline for expressions of interest is 31 January 2014.

For further information and to submit an expression of interest please visit the Breast Cancer Campaign’s website.

Please also be aware that the BCC are also currently calling for full applications in any area of breast cancer research – visit their website for more information.